Company

Sermonix Pharmaceuticals

Pharmaceutical Manufacturing 250 E Broad St 14 employees

Employees: 14
Contacts: 2
Emails: 2
Phones: 1

sermonixpharma.com LinkedIn

Sermonix Pharmaceuticals Overview

Headquarters: 250 E Broad St
Website: sermonixpharma.com
Industry: Pharmaceutical Manufacturing
Employees: 14
Founded: 2014
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

About Sermonix Pharmaceuticals

Sermonix Pharmaceuticals, founded by David Portman, MD—a leading clinical researcher and expert in women’s health—focuses on developing targeted therapeutics to treat ESR1-mutated metastatic breast and gynecological cancers. Our ELAINE Studies are evaluating an investigational oral drug, lasofoxifene, a novel targeted endocrine agent, in women and men with locally advanced or metastatic estrogen receptor-positive/human epidermal growth factor 2-negative (ER+/HER2-) breast cancer harboring an ESR1 mutation(s).

Sermonix Pharmaceuticals Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Sermonix Pharmaceuticals Org Chart

Sample employees and titles

Name	Title	Location	Contact
Gina Gasper	Clinical Operations Executive		View
Miriam Portman	Chief Operating Officer	Columbus, Ohio, United States	Email
Thomas Pfisterer	Director Direct Investments (Cio-di) @		View
Barry Komm		Greater Philadelphia, United States	Email Phone